[VIDEO] Do you have the rights to use CRISPR-based tools – Joint video with Genoway, Merck and Questel

    With more than 1200 patent families with claims including CRISPR, do you actually know whether you are infringing on third-party rights when using this technology?

    Four industry experts provide meaningful insights and feedback in this webinar on the following topics:

    1) Use of CRISPR for model generation (Amélie Rezza, genOway)

    2) Overview of CRISPR patent landscape (Mathieu Fontaine, Questel)

    3) Coverage of specific Merck CRISPR-enabling process (Ajay Rastogi, Merck)

    4) Freedom to use CRISPR/Cas9-based tools (Sandrine Carteau, genOway)

    👇 This content is restricted, please login or register to view the content 👇